Back
BioNTech SE Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
43
BNTX
BioNTech SE
Last Price:
$94.50
Seasonality Move:
39.68%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BioNTech SE Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 97.6 | Sell |
20-day SMA: | 101.76 | Sell |
50-day SMA: | 99.72 | Sell |
200-day SMA: | 106.32 | Sell |
8-day EMA: | 97.32 | Sell |
20-day EMA: | 99.28 | Sell |
50-day EMA: | 101.68 | Sell |
200-day EMA: | 105.12 | Sell |
BioNTech SE Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.22 | Sell |
Relative Strength Index (14 RSI): | 47.29 | Sell |
Chaikin Money Flow: | 716808 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.29 - 107.11) | Sell |
Bollinger Bands (100): | (97.84 - 119) | Sell |
BioNTech SE Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BioNTech SE Stock
Is BioNTech SE Stock a Buy?
-
BioNTech SE share price is 97.27 while BNTX 8-day simple moving average is 97.60, which is a Sell signal.
-
The stock price of BNTX is 97.27 while BioNTech SE 20-day SMA is 101.76, which makes it a Sell.
-
BioNTech SE 50-day simple moving average is 99.72 while BNTX share price is 97.27, making it a Sell technically.
-
BNTX stock price is 97.27 and BioNTech SE 200-day simple moving average is 106.32, creating a Sell signal.
BNTX Technical Analysis vs Fundamental Analysis
Sell
43
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy or a Sell?
-
BioNTech SE stock is rated a SellThe current BioNTech SE [BNTX] share price is $97.27. The Score for BNTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
BioNTech SE Stock Info
Market Cap:
23.4B
Price in USD:
97.27
Share Volume:
818.2K
BioNTech SE 52-Week Range
52-Week High:
131.49
52-Week Low:
76.53
Sell
43
BioNTech SE (BNTX)
is a Sell
BioNTech SE Share Price Forecast
-
What is the BioNTech SE stock price today?The BioNTech SE stock price is 97.27 USD today.
-
Will BNTX stock go up or go down?BioNTech SE> share price is forecast to RISE/FALL based on technical indicators
-
Is BioNTech SE overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioNTech SE is overvalued.
Is BioNTech SE Stock a Buy?
-
BioNTech SE share price is 97.27 while BNTX 8-day exponential moving average is 97.32, which is a Sell signal.
-
The stock price of BNTX is 97.27 while BioNTech SE 20-day EMA is 99.28, which makes it a Sell.
-
BioNTech SE 50-day exponential moving average is 101.68 while BNTX share price is 97.27, making it a Sell technically.
-
BNTX stock price is 97.27 and BioNTech SE 200-day simple moving average is 105.12, creating a Sell signal.
Fundamental Analysis of BioNTech SE
Is BioNTech SE a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.87 per share, a decrease next quarter of $2.12 per share, a decrease this year of $2.41 per share, and an increase next year of $0.14 per share.
Technical Analysis of BioNTech SE
Should I short BioNTech SE stock?
-
BNTX Moving Average Covergence Divergence (MACD) indicator is -1.22, suggesting BioNTech SE is a Sell
-
BioNTech SE Relative Strength Index (RSI) is 47.29, which suggest BioNTech SE is oversold
-
The Bollinger Bands (25) for BioNTech SE is (92.29 - 107.11), which suggest BioNTech SE is a Sell
-
The Bollinger Bands (100) for BioNTech SE is (97.84 - 119), which suggest BioNTech SE is a Sell
* BioNTech SE stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.